A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

NCT01343277 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

579

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Liposarcoma or Leiomyosarcoma

Interventions

DRUG: Trabectedin
DRUG: Dacarbazine

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]